Table 3.
5HTTLPR diallelic | 5HTTLPR triallelic | BDNF val66met | |||||
---|---|---|---|---|---|---|---|
MDD | All | S carriers | L/L | S or LG carriers | LA/LA | Met carriers | Val/Val |
N | 84 | 53 | 28 | 58 | 21 | 32 | 47 |
Age | 48.82 (8.93) | 49.6 (8.3) | 47.18 (9.9) | 49.12 (8.6) | 48.5 (10.1) | 50.09 (10.2) | 47.70 (8.0) |
Sex (male/female) | 27/57 | 17/36 | 9/19 | 19/39 | 6/15 | 6/23 | 16/31 |
IQ | 117.18 (11.3) | 117.21 (11.8) | 117.21 (11.3) | 117.21 (11.5) | 117.19 (12.3) | 113.56 (12.5) | 116.63 (11.0) |
BDI | 15.25 (11.3) | 15.23 (11.2) | 16.54 (11.7) | 14.9 (10.9) | 16.95 (12.7) | 17.38 (13.4) | 14.3 (10.0) |
Medicated/unmedicated | 59/25 | 42/11 | 15/13 | 44/14 | 12/9 | 25/7 | 31/16 |
Raw HCV (mm3) | |||||||
Left | 1671.50 (237.93) | 1676.01 (254.58) | 1674.92 (218.29) | 1672.89 (247.96) | 1659.15 (214.30) | 1613.34 (281.74) | 1693.89 (204.3) |
Right | 1928.47 (248.21) | 1931.92 (263.31) | 1937.45 (228.42) | 1933.46 (257.31) | 1899.77 (206.96) | 1850.73 (268.14) | 1965.93 (228.5) |
Normalized HCV | |||||||
Left | 1.13 (0.16) | 1.14 (0.18) | 1.12 (0.13) | 1.13 (0.18) | 1.13 (0.13) | 1.13 (0.19) | 1.13 (0.16) |
Right | 1.30 (0.18) | 1.31 (0.19) | 1.29 (0.14) | 1.31 (0.19) | 1.30 (0.14) | 1.30 (0.19) | 1.32 (0.18) |
ICV (mm3) | 1 486 882 (150 096) | 1 480 222 (147 488) | 1 507 214 (156 562) | 1 490 172 (158 016) | 1 468 301 (119 160) | 1 435 285 (148 783)* | 1 513 238 (147 989)* |
Denotes significant differences within genotype. All other comparisons within genotype were not significantly different (P > 0.05).